Literature DB >> 15930137

Insights into Lafora disease: malin is an E3 ubiquitin ligase that ubiquitinates and promotes the degradation of laforin.

Matthew S Gentry1, Carolyn A Worby, Jack E Dixon.   

Abstract

Lafora disease (LD) is a fatal form of progressive myoclonus epilepsy caused by recessive mutations in either a gene encoding a dual-specificity phosphatase, known as laforin, or a recently identified gene encoding the protein known as malin. Here, we demonstrate that malin is a single subunit E3 ubiquitin (Ub) ligase and that its RING domain is necessary and sufficient to mediate ubiquitination. Additionally, malin interacts with and polyubiquitinates laforin, leading to its degradation. Missense mutations in malin that are present in LD patients abolish its ability to polyubiquitinate and signal the degradation of laforin. Our results demonstrate that laforin is a physiologic substrate of malin, and we propose possible models to explain how recessive mutations in either malin or laforin result in LD. Furthermore, these data distinguish malin as an E3 Ub ligase whose activity is necessary to prevent a neurodegenerative disease that involves formation of nonproteinacious inclusion bodies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15930137      PMCID: PMC1150849          DOI: 10.1073/pnas.0503285102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  53 in total

1.  A sensitive assay for phosphoinositide phosphatases.

Authors:  T Maehama; G S Taylor; J T Slama; J E Dixon
Journal:  Anal Biochem       Date:  2000-03-15       Impact factor: 3.365

Review 2.  RING domains: master builders of molecular scaffolds?

Authors:  K L Borden
Journal:  J Mol Biol       Date:  2000-02-04       Impact factor: 5.469

Review 3.  Transcriptional regulation: Kamikaze activators.

Authors:  D Thomas; M Tyers
Journal:  Curr Biol       Date:  2000-05-04       Impact factor: 10.834

4.  Structure of a c-Cbl-UbcH7 complex: RING domain function in ubiquitin-protein ligases.

Authors:  N Zheng; P Wang; P D Jeffrey; N P Pavletich
Journal:  Cell       Date:  2000-08-18       Impact factor: 41.582

5.  Diverse roles for ubiquitin-dependent proteolysis in transcriptional activation.

Authors:  J Russell Lipford; Raymond J Deshaies
Journal:  Nat Cell Biol       Date:  2003-10       Impact factor: 28.824

6.  PIAS proteins modulate transcription factors by functioning as SUMO-1 ligases.

Authors:  Noora Kotaja; Ulla Karvonen; Olli A Jänne; Jorma J Palvimo
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

Review 7.  Ubiquitin: not just for proteasomes anymore.

Authors:  Rubén Claudio Aguilar; Beverly Wendland
Journal:  Curr Opin Cell Biol       Date:  2003-04       Impact factor: 8.382

8.  Myotubularin, a protein tyrosine phosphatase mutated in myotubular myopathy, dephosphorylates the lipid second messenger, phosphatidylinositol 3-phosphate.

Authors:  G S Taylor; T Maehama; J E Dixon
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

9.  Model of the brain tumor-Pumilio translation repressor complex.

Authors:  Thomas A Edwards; Brian D Wilkinson; Robin P Wharton; Aneel K Aggarwal
Journal:  Genes Dev       Date:  2003-10-15       Impact factor: 11.361

10.  Mutations in NHLRC1 cause progressive myoclonus epilepsy.

Authors:  Elayne M Chan; Edwin J Young; Leonarda Ianzano; Iulia Munteanu; Xiaochu Zhao; Constantine C Christopoulos; Giuliano Avanzini; Maurizio Elia; Cameron A Ackerley; Nebojsa J Jovic; Saeed Bohlega; Eva Andermann; Guy A Rouleau; Antonio V Delgado-Escueta; Berge A Minassian; Stephen W Scherer
Journal:  Nat Genet       Date:  2003-09-07       Impact factor: 38.330

View more
  94 in total

1.  Increased laforin and laforin binding to glycogen underlie Lafora body formation in malin-deficient Lafora disease.

Authors:  Erica Tiberia; Julie Turnbull; Tony Wang; Alessandra Ruggieri; Xiao-Chu Zhao; Nela Pencea; Johan Israelian; Yin Wang; Cameron A Ackerley; Peixiang Wang; Yan Liu; Berge A Minassian
Journal:  J Biol Chem       Date:  2012-06-05       Impact factor: 5.157

2.  Genetic depletion of the malin E3 ubiquitin ligase in mice leads to lafora bodies and the accumulation of insoluble laforin.

Authors:  Anna A DePaoli-Roach; Vincent S Tagliabracci; Dyann M Segvich; Catalina M Meyer; Jose M Irimia; Peter J Roach
Journal:  J Biol Chem       Date:  2010-06-10       Impact factor: 5.157

3.  The laforin-malin complex negatively regulates glycogen synthesis by modulating cellular glucose uptake via glucose transporters.

Authors:  Pankaj Kumar Singh; Sweta Singh; Subramaniam Ganesh
Journal:  Mol Cell Biol       Date:  2011-11-28       Impact factor: 4.272

Review 4.  Lafora disease: epidemiology, pathophysiology and management.

Authors:  Thomas S Monaghan; Norman Delanty
Journal:  CNS Drugs       Date:  2010-07       Impact factor: 5.749

Review 5.  Glycogen phosphorylation and Lafora disease.

Authors:  Peter J Roach
Journal:  Mol Aspects Med       Date:  2015-08-13

6.  Glycogen metabolism in tissues from a mouse model of Lafora disease.

Authors:  Wei Wang; Hannes Lohi; Alexander V Skurat; Anna A DePaoli-Roach; Berge A Minassian; Peter J Roach
Journal:  Arch Biochem Biophys       Date:  2006-11-03       Impact factor: 4.013

Review 7.  Lafora disease, seizures and sugars.

Authors:  D M Andrade; J Turnbull; B A Minassian
Journal:  Acta Myol       Date:  2007-07

Review 8.  Advances in lafora progressive myoclonus epilepsy.

Authors:  Antonio V Delgado-Escueta
Journal:  Curr Neurol Neurosci Rep       Date:  2007-09       Impact factor: 5.081

9.  Distinct mutations in the glycogen debranching enzyme found in glycogen storage disease type III lead to impairment in diverse cellular functions.

Authors:  Alan Cheng; Mei Zhang; Minoru Okubo; Kaoru Omichi; Alan R Saltiel
Journal:  Hum Mol Genet       Date:  2009-03-19       Impact factor: 6.150

10.  Abnormal metabolism of glycogen phosphate as a cause for Lafora disease.

Authors:  Vincent S Tagliabracci; Jean Marie Girard; Dyann Segvich; Catalina Meyer; Julie Turnbull; Xiaochu Zhao; Berge A Minassian; Anna A Depaoli-Roach; Peter J Roach
Journal:  J Biol Chem       Date:  2008-10-13       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.